AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Liabilities
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Other Operating Liabilities of $188.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2016-05-05
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2016-03-31 was $188.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2015-12-31 was $66.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2015-09-30 was $2.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2015-06-30 was $3.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for fiscal 2015 was $41.00K, a 46.43% increase from fiscal 2014.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating liabilities for fiscal 2014 was $28.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2016-03-31 | $188.00K 10-Q · filed 2016-05-05 | $254.00K derived: sum of 2 quarters · filed 2016-05-05 | $256.00K derived: sum of 3 quarters · filed 2016-05-05 | $259.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2015-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $68.00K derived: sum of 2 quarters · filed 2016-03-14 | $71.00K derived: sum of 3 quarters · filed 2016-03-14 | $41.00K 10-K · filed 2016-03-14 | |
| 2015-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.00K derived: sum of 2 quarters · filed 2015-11-09 | -$25.00K 10-Q · filed 2015-11-09 | -$26.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2015-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$27.00K 10-Q · filed 2015-08-11 | -$28.00K derived: sum of 3 quarters · filed 2016-05-05 | -$29.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2015-03-31 | -$30.00K 10-Q · filed 2016-05-05 | -$31.00K derived: sum of 2 quarters · filed 2016-05-05 | -$32.00K derived: sum of 3 quarters · filed 2016-05-05 | -$32.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2014-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$2.00K derived: sum of 2 quarters · filed 2016-03-14 | -$2.00K derived: sum of 3 quarters · filed 2016-03-14 | $28.00K 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.00K derived: sum of 2 quarters · filed 2015-11-09 | $29.00K 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $30.00K 10-Q · filed 2015-08-11 | $29.53K 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $30.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |